A prospective study to evaluate the effect of midazolam before surgery on nausea, vomiting prevention and anesthesia recovery time in gynecologic day surgery

The effect of midazolam on postoperative nausea, vomiting prevention and anesthesia recovery time in gynecological outpatients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002692

Enrollment

Registered

2018-02-14

Start date

2018-03-19

Completion date

Unknown

Last updated

2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Before surgery, the patients are divided into two groups: midazolam 50 mcg / kg intravenously and normal saline only intravenously.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who receive gynecologic surgery through the outpatient clinic and return home on the day.

Exclusion criteria

Exclusion criteria: Patients with severe motion sickness or previous history of postoperative nausea and vomiting.

Design outcomes

Primary

Measure	Time frame
postoperative nausea and vomiting	—

Secondary

Measure	Time frame
Length of recovery room stay	—

Countries

Korea, Republic of

Contacts

Public ContactHyun Jee Kim

Keimyung University

dittojee@naver.com+82-53-250-7240

Outcome results